Sign up here and take full advantage of MicrobiomePost‘s features.

Hafnia alvei HA4597

Overview

Hafnia alvei is the first precision probiotic developed based on a target-based approach and a screening for strains producing ClpB, a protein mimicking alpha-MSH and activating the signals of satiety. Its mechanism of action and demonstration in efficacy in mice and humans make it a uniquely positioned, innovative next-gen probiotic for weight management.

Scientific reference(s)

https://www.mdpi.com/2072-6643/13/6/1902

https://pubmed.ncbi.nlm.nih.gov/27616451/

https://pubmed.ncbi.nlm.nih.gov/31911661/

https://pubmed.ncbi.nlm.nih.gov/31878078/

Additional info

Therapeutical area(s)

Gut brain Axis · Cardiometabolic · Weight management

Functionality

Satiety

Age/Gender

Adults · Women

Search strain on Pubmed

Hafnia alvei HA4597 is available at

MicrobiomeHUB_Logo_TargEDys

TargEDys

Postbiotics + Probiotic Strains

Take full advantage of MicrobiomePost's features